Safety and Efficacy Evaluation of S (+) - Ketamine in Adults

NCT04837170 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12000

Last updated 2021-04-08

No results posted yet for this study

Summary

A multicenter, randomized, open-label, active controlled pragmatic clinical trial that evaluates the safety and efficacy of S (+) -ketamine for postoperative acute pain in adults in perioperative settings.

Conditions

  • Postoperative Pain
  • Adults
  • Anesthesia

Interventions

DRUG

Conventional therapy + S (+)-Ketamine

Patients who undergo general anesthesia using S(+)-ketamine hydrochloride for anesthesia induction,maintenance or postoperative analgesia.

DRUG

Conventional therapy

Receiving conventional therapy without S (+)-Ketamine hydrochloride injection. There is no restrictions in drugs, doses and incompatibility, the researchers can choose appropriate medication regimens based on clinical practice, but other NMDA receptor antagonists are not be allowed to use, such as dextromethorphan and amantadine.

Sponsors & Collaborators

  • Jiangsu Provincial People's Hospital

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Southern Medical University, China

    collaborator OTHER
  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Weidong Mi, MD · Chinese PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-06-01
Completion
2022-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04837170 on ClinicalTrials.gov